1. Home
  2. MYE vs SAGE Comparison

MYE vs SAGE Comparison

Compare MYE & SAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYE
    SELLHOLDBUYas of in 21 minutes
  • SAGE
    SELLHOLDBUYas of in 21 minutes
  • Stock Information
  • Founded
  • MYE 1933
  • SAGE 2010
  • Country
  • MYE United States
  • SAGE United States
  • Employees
  • MYE N/A
  • SAGE N/A
  • Industry
  • MYE Auto Parts:O.E.M.
  • SAGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • MYE Consumer Discretionary
  • SAGE Health Care
  • Exchange
  • MYE Nasdaq
  • SAGE Nasdaq
  • Market Cap
  • MYE 449.5M
  • SAGE 474.6M
  • IPO Year
  • MYE N/A
  • SAGE 2014
  • Fundamental
  • Price
  • MYE $12.02
  • SAGE $7.89
  • Analyst Decision
  • MYE Hold
  • SAGE Hold
  • Analyst Count
  • MYE 1
  • SAGE 19
  • Target Price
  • MYE N/A
  • SAGE $9.88
  • AVG Volume (30 Days)
  • MYE 449.7K
  • SAGE 1.2M
  • Earning Date
  • MYE 03-06-2025
  • SAGE 04-24-2025
  • Dividend Yield
  • MYE 4.51%
  • SAGE N/A
  • EPS Growth
  • MYE N/A
  • SAGE N/A
  • EPS
  • MYE 0.19
  • SAGE N/A
  • Revenue
  • MYE $836,281,000.00
  • SAGE $41,243,000.00
  • Revenue This Year
  • MYE $4.21
  • SAGE $100.39
  • Revenue Next Year
  • MYE $3.55
  • SAGE $70.86
  • P/E Ratio
  • MYE $62.63
  • SAGE N/A
  • Revenue Growth
  • MYE 2.85
  • SAGE N/A
  • 52 Week Low
  • MYE $9.32
  • SAGE $4.62
  • 52 Week High
  • MYE $23.22
  • SAGE $18.76
  • Technical
  • Relative Strength Index (RSI)
  • MYE 49.40
  • SAGE 51.23
  • Support Level
  • MYE $11.70
  • SAGE $7.99
  • Resistance Level
  • MYE $12.28
  • SAGE $8.81
  • Average True Range (ATR)
  • MYE 0.34
  • SAGE 0.30
  • MACD
  • MYE -0.08
  • SAGE -0.03
  • Stochastic Oscillator
  • MYE 23.02
  • SAGE 23.01

Stock Price Comparison Chart: MYE vs SAGE

MYE
SAGE
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April01020304050607080MYE VS SAGE

About MYE Myers Industries Inc.

Myers Industries Inc designs, manufactures, and markets a variety of plastic, metal, and rubber products, including a broad selection of plastic reusable containers, pallets, small parts bins, bulk shipping containers, storage and organization products, OEM parts, custom plastic products, consumer fuel containers and tanks for water, fuel and waste handling. It operates through the following segments: The Material Handling segment, which designs manufactures, and markets a variety of plastic and metal products. The Distribution segment offers tools, equipment, and supplies used for tire, wheel, and under-vehicle service on passenger, heavy truck, and off-road vehicles. It generates the majority of its revenue from the Material Handling segment.

About SAGE Sage Therapeutics Inc.

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use